SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-027860
Filing Date
2023-06-01
Accepted
2023-06-01 20:40:34
Documents
2
Period of Report
2023-05-31

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 7925
2 EXHIBIT 99.1 brhc20053901_99-1.htm EX-99.1 10822
  Complete submission text file 0001140361-23-027860.txt   20060
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Issuer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address
Blume-Jensen Peter (Reporting) CIK: 0001950499 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41551 | Film No.: 23986464